This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Organon R&d Finland Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sanna Niinivehmas: Pharmaceutical Chemistry Inventor
Introduction
Sanna Niinivehmas is an inventor associated with Littoinen, Finland. Her patent work concerns heterocyclic compounds and their potential pharmaceutical applications. She is credited with 1 patent.
Latest Patents
Niinivehmas’s patent, “Heterocyclic Compounds, Compositions, Methods of Preparation and Uses Thereof,” describes compounds of a specified formula, along with their salts and solvates, and pharmaceutical compositions containing them as active ingredients. The invention also addresses the compounds’ use as inhibitors of aldo-keto reductase family 1 C3 (AKR1C3), also known as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5 or HSD17B5) and prostaglandin F2α synthase. It further covers methods for preparing the compounds and their potential uses.
Career Highlights
Niinivehmas’s listed professional affiliations include Organon R&D Finland Ltd. and Organon R&D Finland Oy. Her patent reflects research into compounds that may have pharmaceutical applications through inhibition of AKR1C3 and related enzyme activity.
Collaborations
Her listed coworkers include Tero Linnanen and Kaisa Illikainen. Their names appear alongside Niinivehmas in connection with her professional and patent-related work.
Conclusion
Sanna Niinivehmas’s patent work focuses on heterocyclic compounds, their preparation, and their potential use as enzyme inhibitors, highlighting her contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile